Jon runs the national arrhythmia service for children and adults
with congenital heart disease. He chairs the Cardiac Inherited Diseases Group,
which runs the NZ national cardiac inherited disease registry and
multidisciplinary investigative service of young sudden unexplained death.
Jon chairs the genetic council of the Cardiac Society of Australia
and New Zealand, and the Trans-Tasman Response against sudden Death in the
Young (TRAGADY). He is an editorial board member of Heart Rhythm and has
authored over 120 peer reviewed scientific articles, with a focus on sudden
death syndromes.
How the
Intensivist can Prevent Sudden Cardiac Death in the Young
The
Intensivist’s role is primarily in response to a crisis. Of course prevention
is always better than cure, and following a cardiac arrest the identification
of a familial condition can ultimately lead to other family members being
detected and protected. Following an unexplained (“autopsy negative”) sudden
death in a young person, genetic testing in the deceased and family cardiac
screening has been shown to reveal a diagnosis such as long QT syndrome,
Brugada syndrome and CPVT (catecholaminergic polymorphic ventricular
tachycardia) in over 30% of cases in children and youth. If the person
presenting with cardiac arrest is still alive, even if supportive care is to be
withdrawn, cardiac tests, including drug provocation tests such as adrenaline,
adenosine and ajmaline challenges can reveal a hitherto concealed diagnosis in
more than 60% of cases, including in adults. Such findings guide tests in
family members and potentially avoid large sums of money being spent on testing
family members with genetic testing, echocardiography, stress exercise testing
and cardiac MRI for example. This talk presents a protocol for the
investigation of cardiac arrest on intensive care and gives examples of how
this can make a real difference in preventing sudden death in the community.
|